Hennion & Walsh Asset Management, Inc. Bio Techne Corp Transaction History

Hennion & Walsh Asset Management, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$73.76 - $85.98 $106,066 - $123,639	-1,438 Reduced 9.36%	13,926 $1.14 Million
Q1 2023 Apr 20, 2023	SELL	$71.62 - $86.62 $991,865 - $1.2 Million	-13,849 Reduced 47.41%	15,364 $1.14 Million
Q4 2022 Jan 12, 2023	BUY	$80.67 - $352.29 $1.73 Million - $7.54 Million	21,401 Added 273.95%	29,213 $2.42 Million
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $1.19 Million - $1.65 Million	-4,209 Reduced 35.01%	7,812 $2.22 Million
Q2 2022 Jul 19, 2022	SELL	$322.67 - $449.65 $134,876 - $187,953	-418 Reduced 3.36%	12,021 $4.17 Million
Q1 2022 Apr 26, 2022	SELL	$353.85 - $487.79 $1.33 Million - $1.83 Million	-3,756 Reduced 23.19%	12,439 $5.39 Million
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $601,661 - $692,554	1,319 Added 8.87%	16,195 $8.38 Million
Q3 2021 Nov 12, 2021	BUY	$444.87 - $538.88 $19,574 - $23,710	44 Added 0.3%	14,876 $7.21 Million
Q2 2021 Aug 13, 2021	BUY	$387.35 - $450.26 $253,714 - $294,920	655 Added 4.62%	14,832 $6.68 Million
Q1 2021 May 17, 2021	BUY	$314.62 - $411.0 $4.46 Million - $5.83 Million	14,177 New	14,177 $5.42 Million

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.94B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.